D

Dyadic International
D

DYAI

1.48000
USD
-0.02
(-1.33%)
مغلق
حجم التداول
51
الربح لكل سهم
-0
العائد الربحي
-
P/E
-6
حجم السوق
43,792,269
نظرة عامةالتوصياتالأفكار والتحليلاتالأخبار
أصول ذات صلة
    A
    ABEO
    -0.04000
    (-0.69%)
    5.78000 USD
    A
    ADVM
    -0.03500
    (-0.88%)
    3.95000 USD
    ALNY
    ALNY
    -0.480
    (-0.19%)
    250.450 USD
    B
    BTAI
    -0.22000
    (-9.36%)
    2.13000 USD
    C
    CYCN
    0.18000
    (6.79%)
    2.83000 USD
    D
    DNLI
    -0.840
    (-3.89%)
    20.740 USD
    MRNA
    MRNA
    1.785
    (5.29%)
    35.535 USD
    S
    SLDB
    -0.22000
    (-3.67%)
    5.77500 USD
    V
    VKTX
    2.480
    (7.85%)
    34.090 USD
    V
    VSTM
    0.11500
    (2.06%)
    5.68500 USD
    المزيد
الأخبار
المقالات

العنوان: Dyadic International

القطاع: Healthcare
الصناعة: Biotechnology
Dyadic International Inc is a world-wide biotechnology platform company. The company has developed a gene expression platform for producing commercial quantities of industrial enzymes and other proteins, and has licensed this technology tothird parties, such as Abengoa Bioenergy, BASF, Codexis and others, for use in industrial (non-pharmaceutical) applications. This technology is based on the Thermothelomyces heterothallica fungus, which the company named C1.